Skip to main content

Vitamin and Trace Element Needs in Chronic Kidney Disease

  • Chapter
  • First Online:
Book cover Nutrition in Kidney Disease

Part of the book series: Nutrition and Health ((NH))

  • 2409 Accesses

Abstract

Malnutrition and the broader term of “protein–energy wasting” have the potential to impact not only macronutrient metabolism but also vitamin and trace element status in patients with chronic kidney disease (CKD). Evidence for this is clearly shown in a recent study on vitamin K status. In this study the researchers determined which parameters predicted vitamin K status [1]. Patients with worsening vitamin K status had significantly lower body mass index (BMI), more years on dialysis, higher C-reactive protein (CRP) concentrations, and poorer survival [1]. Thus, those patients with lower body stores and higher inflammation had lower vitamin K serum concentrations and ultimately significantly increased risk of death. This is an excellent example of why vitamin and mineral status should be assessed, problems identified and treated, and clinical symptoms monitored in the CKD population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol. 2011;22(2):387–95.

    Article  CAS  PubMed  Google Scholar 

  2. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis. 2008;51(2):212–23.

    Article  CAS  PubMed  Google Scholar 

  3. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57(4):1688–703.

    Article  CAS  PubMed  Google Scholar 

  4. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65(3):1031–40.

    Article  CAS  PubMed  Google Scholar 

  5. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant. 2009;24(4):1232–7.

    Article  CAS  PubMed  Google Scholar 

  6. Kopple JD, Mercurio K, Blumenkrantz MJ, Jones MR, Tallos J, Roberts C, et al. Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int. 1981;19(5):694–704.

    Article  CAS  PubMed  Google Scholar 

  7. Espe KM, Raila J, Henze A, Krane V, Schweigert FJ, Hocher B, et al. Impact of vitamin A on clinical outcomes in haemodialysis patients. Nephrol Dial Transplant. 2011;26(12):4054–61.

    Article  CAS  PubMed  Google Scholar 

  8. Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Institute of Medicine (U.S.). Panel on Folate Other B Vitamins and Choline, Institute of Medicine (U.S.). Subcommittee on Upper Reference Levels of Nutrients. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 1998.

    Google Scholar 

  9. Combs G. The vitamins, fundamental aspects in nutrition and health. New York: Academic; 1998.

    Google Scholar 

  10. Frank T, Czeche K, Bitsch R, Stein G. Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation. Int J Vitam Nutr Res. 2000;70(4):159–66.

    Article  CAS  PubMed  Google Scholar 

  11. Institute of Medicine. For thiamin, riboflavin, niacin, vitamin B6, folate, B12, pantothenic acid, biotin/choline. Washington, DC: National Academies Press; 2000.

    Google Scholar 

  12. Porrini M, Simonetti P, Ciappellano S, Testolin G, Gentile MG, Manna G, et al. Thiamin, riboflavin and pyridoxine status in chronic renal insufficiency. Int J Vitam Nutr Res. 1989;59(3):304–8.

    CAS  PubMed  Google Scholar 

  13. Joel D, Kopple SGM. Kopple and Massry’s nutritional management of renal disease. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.

    Google Scholar 

  14. Andreucci VE, Fissell RB, Bragg-Gresham JL, Ethier J, Greenwood R, Pauly M, et al. Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients. Am J Kidney Dis. 2004;44(5 Suppl 2):61–7.

    Article  PubMed  Google Scholar 

  15. Seal AJ, Creeke PI, Dibari F, Cheung E, Kyroussis E, Semedo P, et al. Low and deficient niacin status and pellagra are endemic in postwar Angola. Am J Clin Nutr. 2007;85(1):218–24.

    CAS  PubMed  Google Scholar 

  16. Takahashi Y, Tanaka A, Nakamura T, Fukuwatari T, Shibata K, Shimada N, et al. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int. 2004;65(3):1099–104.

    Article  CAS  PubMed  Google Scholar 

  17. Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW. A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(4):1131–8.

    Article  CAS  PubMed  Google Scholar 

  18. Laroche M, Boyer JF. Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. Joint Bone Spine. 2005;72(5):376–81.

    Article  PubMed  Google Scholar 

  19. Berns JS. Niacin and related compounds for treating hyperphosphatemia in dialysis patients. Semin Dial. 2008;21(3):203–5.

    Article  PubMed  Google Scholar 

  20. Feig DI. Uric acid and hypertension in adolescents. Semin Nephrol. 2005;25(1):32–8.

    Article  CAS  PubMed  Google Scholar 

  21. Podda GM, Lussana F, Moroni G, Faioni EM, Lombardi R, Fontana G, et al. Abnormalities of homocysteine and B vitamins in the nephrotic syndrome. Thromb Res. 2007;120(5):647–52.

    Article  CAS  PubMed  Google Scholar 

  22. Pollock C, McMahon L. The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin. Nephrology. 2005;10 Suppl 4:S108–15.

    Article  PubMed  Google Scholar 

  23. Cano N, Fiaccadori E, Tesinsky P, Toigo G, Druml W, Kuhlmann M, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006;25(2):295–310.

    Article  CAS  PubMed  Google Scholar 

  24. Pollock C, Voss D, Hodson E, Crompton C. The CARI guidelines. Nutrition and growth in kidney disease. Nephrology. 2005;10 Suppl 5:S177–230.

    PubMed  Google Scholar 

  25. Hannisdal R, Ueland PM, Svardal A. Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum. Clin Chem. 2009;55(6):1147–54.

    Article  CAS  PubMed  Google Scholar 

  26. Bastow MD, Woods HF, Walls J. Persistent anemia associated with reduced serum vitamin B12 levels in patients undergoing regular hemodialysis therapy. Clin Nephrol. 1979;11(3):133–5.

    CAS  PubMed  Google Scholar 

  27. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163–70.

    Article  CAS  PubMed  Google Scholar 

  28. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Selhub J, et al. Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney Int. 2005;67(4):1539–46.

    Article  CAS  PubMed  Google Scholar 

  29. Suliman M, Stenvinkel P, Qureshi AR, Kalantar-Zadeh K, Barany P, Heimburger O, et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant. 2007;22(1):209–17.

    Article  PubMed  Google Scholar 

  30. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002;61(2):609–14.

    Article  PubMed  Google Scholar 

  31. House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010;303(16):1603–9.

    Article  CAS  PubMed  Google Scholar 

  32. Institute of Medicine (U.S.). Panel on Dietary Antioxidants and Related Compounds. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids: a report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academy Press; 2000.

    Google Scholar 

  33. Moyad MA, Combs MA, Crowley DC, Baisley JE, Sharma P, Vrablic AS, et al. Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding. Urol Nurs. 2009;29(2):95–102.

    PubMed  Google Scholar 

  34. Chan D, Irish A, Dogra G. Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients. Nephrology (Carlton). 2005;10(4):336–40.

    Article  CAS  Google Scholar 

  35. Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton). 2008;13(1):17–22.

    CAS  Google Scholar 

  36. Zhang K, Liu L, Cheng X, Dong J, Geng Q, Zuo L. Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein. BMC Nephrol. 2011;12:18.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Deved V, Poyah P, James MT, Tonelli M, Manns BJ, Walsh M, et al. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1089–97.

    Article  CAS  PubMed  Google Scholar 

  38. Intakes CoDR. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.

    Google Scholar 

  39. Institute of Medicine (U.S.). Panel on Micronutrients. DRI: dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc : a report of the Panel on Micronutrients … and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academy Press; 2001.

    Google Scholar 

  40. Montazerifar F, Hashemi M, Karajibani M, Dikshit M. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans. J Med Food. 2010;13(6):1490–3.

    Article  CAS  PubMed  Google Scholar 

  41. Frey SK, Nagl B, Henze A, Raila J, Schlosser B, Berg T, et al. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis. 2008;7:29.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Chen J, He J, Ogden LG, Batuman V, Whelton PK. Relationship of serum antioxidant vitamins to serum creatinine in the US population. Am J Kidney Dis. 2002;39(3):460–8.

    Article  CAS  PubMed  Google Scholar 

  43. Smith FR, Goodman DS. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest. 1971;50(11):2426–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Yatzidis H, Digenis P, Fountas P. Hypervitaminosis A accompanying advanced chronic renal failure. Br Med J. 1975;3(5979):352–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Kelleher J, Humphrey CS, Homer D, Davison AM, Giles GR, Losowsky MS. Vitamin A and its transport proteins in patients with chronic renal failure receiving maintenance haemodialysis and after renal transplantation. Clin Sci (Lond). 1983;65(6):619–26.

    CAS  Google Scholar 

  46. Martin-Del-Campo F, Batis-Ruvalcaba C, Gonzalez-Espinoza L, Rojas-Campos E, Angel JR, Ruiz N, et al. Dietary micronutrient intake in peritoneal dialysis patients: relationship with nutrition and inflammation status. Perit Dial Int. 2012;32(2):183–91.

    Article  CAS  PubMed  Google Scholar 

  47. Kalousova M, Kubena AA, Kostirova M, Vinglerova M, Ing OM, Dusilova-Sulkova S, et al. Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis. 2010;56(3):513–21.

    Article  CAS  PubMed  Google Scholar 

  48. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, et al. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2008;28(3):397–404.

    Article  CAS  PubMed  Google Scholar 

  49. Galli F, Buoncristiani U, Conte C, Aisa C, Floridi A. Vitamin E in uremia and dialysis patients. Ann N Y Acad Sci. 2004;1031:348–51.

    Article  CAS  PubMed  Google Scholar 

  50. Mann JF, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, et al. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int. 2004;65(4):1375–80.

    Article  CAS  PubMed  Google Scholar 

  51. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293(11):1338–47.

    Article  PubMed  Google Scholar 

  52. Miller III ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37–46.

    Article  CAS  PubMed  Google Scholar 

  53. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356(9237):1213–8.

    Article  CAS  PubMed  Google Scholar 

  54. Roozbeh J, Shahriyari B, Akmali M, Vessal G, Pakfetrat M, Raees Jalali GA, et al. Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis. Ren Fail. 2011;33(2):118–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL. Vitamins K and D status in stages 3–5 chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(4):590–7.

    Article  CAS  PubMed  Google Scholar 

  56. Prasad GV, Rossi NF. Arsenic intoxication associated with tubulointerstitial nephritis. Am J Kidney Dis. 1995;26(2):373–6.

    Article  CAS  PubMed  Google Scholar 

  57. Griffin JL, Walker LA, Troke J, Osborn D, Shore RF, Nicholson JK. The initial pathogenesis of cadmium induced renal toxicity. FEBS Lett. 2000;478(1–2):147–50.

    Article  CAS  PubMed  Google Scholar 

  58. Dartsch PC, Hildenbrand S, Kimmel R, Schmahl FW. Investigations on the nephrotoxicity and hepatotoxicity of trivalent and hexavalent chromium compounds. Int Arch Occup Environ Health. 1998;71(Suppl):S40–5.

    PubMed  Google Scholar 

  59. Takeuchi A, Yoshizawa N, Oshima S, Kubota T, Oshikawa Y, Akashi Y, et al. Nephrotoxicity of germanium compounds: report of a case and review of the literature. Nephron. 1992;60(4):436–42.

    Article  CAS  PubMed  Google Scholar 

  60. Staessen JA, Nawrot T, Hond ED, Thijs L, Fagard R, Hoppenbrouwers K, et al. Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet. 2001;357(9269):1660–9.

    Article  CAS  PubMed  Google Scholar 

  61. Nuyts GD, Van Vlem E, Thys J, De Leersnijder D, D’Haese PC, Elseviers MM, et al. New occupational risk factors for chronic renal failure. Lancet. 1995;346(8966):7–11.

    Article  CAS  PubMed  Google Scholar 

  62. Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis. 2006;47(1):42–50.

    Article  CAS  PubMed  Google Scholar 

  63. Cuppari L, Carvalho AB, Draibe SA. Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr. 2008;18(5):408–14.

    Article  PubMed  Google Scholar 

  64. Durak I, Akyol O, Basesme E, Canbolat O, Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 1994;66(1):76–80.

    Article  CAS  PubMed  Google Scholar 

  65. Mimic-Oka J, Simic T, Djukanovic L, Reljic Z, Davicevic Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol. 1999;51(4):233–41.

    CAS  PubMed  Google Scholar 

  66. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron. 1991;57(1):10–5.

    Article  CAS  PubMed  Google Scholar 

  67. Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL. Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem. 2011;44(4):275–80.

    Article  CAS  PubMed  Google Scholar 

  68. Mimic-Oka J, Savic-Radojevic A, Pljesa-Ercegovac M, Opacic M, Simic T, Dimkovic N, et al. Evaluation of oxidative stress after repeated intravenous iron supplementation. Ren Fail. 2005;27(3):345–51.

    CAS  PubMed  Google Scholar 

  69. Klevay LM. Ischemic heart disease: nutrition or pharmacotherapy? J Trace Elem Electrolytes Health Dis. 1993;7(2):63–9.

    CAS  PubMed  Google Scholar 

  70. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(3 Suppl):II56–65.

    CAS  PubMed  Google Scholar 

  71. Food and Nutrition Board Institute of Medicine. Molybdenum. In: Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001. p. 420–41.

    Google Scholar 

  72. Hosokawa S, Yoshida O. Role of molybdenum in chronic hemodialysis patients. Int J Artif organs. 1994;17(11):567–9.

    CAS  PubMed  Google Scholar 

  73. Smythe WR, Alfrey AC, Craswell PW, Crouch CA, Ibels LS, Kubo H, et al. Trace element abnormalities in chronic uremia. Ann Intern Med. 1982;96(3):302–10.

    Article  CAS  PubMed  Google Scholar 

  74. Benigno V, Canonica CS, Bettinelli A, von Vigier RO, Truttmann AC, Bianchetti MG. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant. 2000;15(5):605–10.

    Article  CAS  PubMed  Google Scholar 

  75. da Silva CJ, da Rocha AJ, Jeronymo S, Mendes MF, Milani FT, Maia Jr AC, et al. A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. AJNR Am J Neuroradiol. 2007;28(8):1474–9.

    Article  PubMed  Google Scholar 

  76. Gropper S, Smith J, Groff J. Advanced nutrition and human metabolism. Belmont, CA: Wadsworth Cengage Learning; 2009.

    Google Scholar 

  77. Zachara BA, Koterska D, Manitius J, Sadowski L, Dziedziczko A, Salak A, et al. Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure. Biol Trace Elem Res. 2004;97(1):15–30.

    Article  CAS  PubMed  Google Scholar 

  78. Stockler-Pinto MB, Mafra D, Farage NE, Boaventura GT, Cozzolino SM. Effect of Brazil nut supplementation on the blood levels of selenium and glutathione peroxidase in hemodialysis patients. Nutrition. 2010;26(11–12):1065–9.

    Article  CAS  PubMed  Google Scholar 

  79. Piper CM. Very-low-protein diets in chronic renal failure: nutrient content and guidelines for supplementation. J Am Diet Assoc. 1985;85(10):1344–6.

    CAS  PubMed  Google Scholar 

  80. McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001;59(6):2267–72.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alison L. Steiber Ph.D., R.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Steiber, A.L., Chazot, C., Kopple, J.D. (2014). Vitamin and Trace Element Needs in Chronic Kidney Disease. In: Byham-Gray, L., Burrowes, J., Chertow, G. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-685-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-685-6_24

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-684-9

  • Online ISBN: 978-1-62703-685-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics